Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors

Table 2

PET metabolic and blood flow measures in AG-defined ROIs in the tumor and in the symmetric region of contralateral hemisphere.

Participant	AG		CMRGlu		CMRO2		CBF
	Tumor	Contralateral	Tumor	Contralateral	Tumor	Contralateral	Tumor	Contralateral
1	358	22	1.01	1.06	0.59	1.10	0.87	0.99
2	356	−37	0.93	1.06	0.49	1.09	0.83	1.07
3	374	38	1.03	1.18	0.60	1.21	0.80	1.14
4	350	−6	0.96	1.02	0.57	1.06	0.91	0.99
5	311	95	0.89	0.81	0.54	0.69	0.80	0.75
6	289	16	0.97	1.10	0.57	1.02	0.90	1.08
7	413	69	1.12	1.03	0.47	0.87	0.79	0.80
8	289	−5	0.81	0.88	0.50	0.92	0.64	0.93
9	183	59	0.69	0.79	0.47	0.71	0.79	0.77